By apyxmedical In 2019 Shareholder News, 2020 Shareholder News, J-Plasma, RenuvionPosted January 13, 2020APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2019 REVENUE RESULTS READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted December 3, 2019APYX MEDICAL CORPORATION ANNOUNCES SUBJECT ENROLLMENT INITIATED IN NEW STUDY EVALUATING THE USE OF RENUVION® TECHNOLOGY IN DERMAL RESURFACING PROCEDURES READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted November 11, 2019APYX MEDICAL CORPORATION REPORTS THIRD QUARTER OF 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOK READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted November 4, 2019APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER AND DECEMBER READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted October 14, 2019APYX MEDICAL CORPORATION ANNOUNCES SUBJECT ENROLLMENT INITIATED IN STUDY EVALUATING THE USE OF RENUVION® TECHNOLOGY IN SKIN LAXITY PROCEDURES IN THE NECK AND SUBMENTAL REGION READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted October 14, 2019APYX MEDICAL CORPORATION RECEIVES 510(K) CLEARANCE FOR THE APYX PLASMA/RF HANDPIECE READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted September 24, 2019APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON NOVEMBER 11, 2019 READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted August 22, 2019APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER AND OCTOBER READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted August 7, 2019APYX MEDICAL CORPORATION REPORTS SECOND QUARTER AND FIRST HALF OF 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOK READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted August 6, 2019APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF MINNIE BAYLOR-HENRY TO THE COMPANY’S BOARD OF DIRECTORS READ MORE
